文献速递心力衰竭与心肌病

心衰住院后跨射血分数谱的强化药物治疗上调:STRONG-HF 分析

Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

STRONG-HF 试验纳入因急性心衰住院且未达目标剂量的患者,随机接受高强度治疗(快速上调口服药并密切随访)或常规治疗,主要终点为180天心衰再住院或全因死亡。按基线 LVEF 分层分析显示,高强度治疗获益在全程 LVEF 谱一致,严重不良事件与 LVEF 无关。

要点

  • 急性心衰住院后快速上调口服药并密切随访的获益不依赖基线 LVEF。
  • LVEF≤40% 与 >40% 患者的主要终点获益一致,交互作用无统计学意义。
  • 严重不良事件与 LVEF 无关,支持跨射血分数谱应用该策略。

核心结论

  • 急性心衰住院后快速上调口服心衰药物并密切随访可降低180天死亡和心衰再住院,且不依赖基线 LVEF。

研究设计与样本

  • STRONG-HF 随机对照试验的亚组分析,共纳入1078例因急性心衰住院且未使用全额剂量肾素-血管紧张素抑制剂、β受体阻滞剂和盐皮质激素受体拮抗剂的患者。

主要发现

  • 731例(68%)基线 LVEF≤40%,347例(32%)LVEF>40%。
  • 高强度治疗对主要终点(180天心衰再住院或全因死亡)的获益在全程 LVEF 谱一致,LVEF 作为连续变量的交互作用 P=0.372。
  • EQ-5D 视觉模拟量表从基线至90天变化均值在高 LVEF 值略大,但 LVEF 作为连续变量与治疗策略无交互作用(交互作用 P=0.358)。
  • 严重不良事件与 LVEF 无关。

临床怎么用

  • 对急性心衰住院后未达目标剂量的患者,可考虑快速上调口服心衰药物并密切随访,无需因基线 LVEF 不同而区别对待。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute heart failure (AHF) is associated with a poor prognosis regardless of left ventricular ejection fraction (LVEF). STRONG-HF showed the efficacy and safety of a strategy of rapid uptitration of oral treatment for heart failure (HF) and close follow-up (high-intensity care), compared with usual care, in patients recently hospitalized for AHF and enrolled independently from their LVEF. OBJECTIVES: In this study, we sought to assess the impact of baseline LVEF on the effects of high-intensity care vs usual care in STRONG-HF. METHODS: The STRONG-HF trial enrolled patients hospitalized for AHF with any LVEF and not treated with full doses of renin-angiotensin inhibitors, beta-blockers, and mineralocorticoid receptor antagonists. High-intensity care with uptitration of oral medications was performed independently from LVEF. The primary endpoint was the composite of HF rehospitalization or all-cause death at day 180. RESULTS: Among the 1,078 patients randomized, 731 (68%) had LVEF ≤40% and 347 (32%) had LVEF >40%. The treatment benefit of high-intensity care vs usual care on the primary endpoint was consistent across the whole LVEF spectrum (interaction P with LVEF as a continuous variable = 0.372). Mean difference in the EQ-5D visual analog scale change from baseline to day 90 between treatment arms was slightly greater at higher LVEF values, but with no interaction between LVEF as a continuous variable and the treatment strategy (interaction P = 0.358). Serious adverse events were also independent from LVEF. CONCLUSIONS: Rapid uptitration of oral medications for HF and close follow-up reduce 180-day death and HF rehospitalization after AHF hospitalization independently from LVEF. (Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-ProBNP Testing, of Heart Failure Therapies [STRONG-HF]; NCT03412201).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Pagnesi, Metra, Cohen-Solal, et al. Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction. J Am Coll Cardiol. 2023. PMID: 37257948. doi:10.1016/j.jacc.2023.03.426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。